| Symbol | ONNVF |
|---|---|
| Name | ONCO-INNOVATIONS LTD. |
| Sector | UNDEFINED |
| Region | North America |
| Industry | - |
| Address | T2R 1A5 Canada AB 1309-7th Street SW |
| Telephone | +1 2365210626 |
| Fax | — |
| — | |
| Website | https://oncoinnovations.com/ |
| Incorporation | CA |
| Incorporated On | 2021 |
| Employees | — |
| Fiscal Year | 4/30 |
| Public Since | — |
| Exchanges | OTC |
| Auditor | Saturna Group Chartered Professional Accountants LLP; |
| Audit Status | AUDITED |
| Reporting Status | International Reporting: CBOE Canada |
| CIK | — |
| Description | Onco-Innovations Limited ("Onco") is a Canadian-based company dedicated to cancer research and treatment, specializing in oncology. Oncos mission is to prevent and cure cancer through pioneering research and innovative solutions. The Company has secured an exclusive worldwide license to patented technology that targets solid tumours, setting new standards in cancer treatment. Oncos commitment to excellence and innovation drives it to develop advanced therapies that improve patient outcomes and offer hope in the fight against cancer. Additional info from OTC: |
No news found.